Endocrine Abstracts

Programmed cell death-1 (PD-1) receptor inhibitor is an immune check point blockade for anticancer treatment and is currently used for various malignancies such as melanoma, non-small cell lung cancer, and so on. However, an immune check point blockade is associated with a risk for immune related adverse events. Among these events, Type 1 diabetes is rare. We present a case of a 52-year-old man, with no previously diabetic history, who developed diabetic ketoacidosis (DKA) aft...

Abstract withdrawn....

Aims: High level of uric acid is known to associate with stroke, coronary artery disease and metabolic syndrome. Some epidemiologic studies suggested that high uric acid level is connected with dyslipidemia. However, this relationship was not examined in type 2 diabetic patients. This study was conducted to investigate the association between serum uric acid level and lipid profiles in type 2 diabetic patients.Methods: A total of 972 type 2 diabetes pati...

Abstract withdrawn....